From myocardial ischemia to heart failure

From myocardial ischemia to heart failure

Summary Myocardial ischemia results in myocardial dysfunction. Recovery may be delayed ('stunning'), or persistent if perfusion remains reduced ('hibernation') and ischemia may go on to necrosis, thus, contributing to chronic heart failure. In addition, myocardium not directly af...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Ertl, G, Fraccarollo, D, Gaudron, P, Hu, K, Laser, A, Neubauer, S, Schorb, W
Formato:	Journal article
Idioma:	German
Publicado em:	1998

Registros relacionados

[Transition of myocardial ischemia to heart failure]
por: Ertl, G, et al.
Publicado em: (1998)

[Possibilities of ACE inhibitor therapy in acute myocardial ischemia]
por: Ertl, G, et al.
Publicado em: (1991)

Possibilities of ACE inhibitor therapy in acute myocardial ischemia
por: Ertl, G, et al.
Publicado em: (1991)

Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction.
por: Hu, K, et al.
Publicado em: (2004)

Clinical studies with vasodilators in heart failure
por: Ertl, G, et al.
Publicado em: (1992)

Regional biochemical remodeling in non-infarcted tissue of rat heart post-myocardial infarction.
por: Laser, A, et al.
Publicado em: (1996)

Long-term beta-blocker treatment prevents chronic creatine kinase and lactate dehydrogenase system changes in rat hearts after myocardial infarction.
por: Laser, A, et al.
Publicado em: (1996)

Cardiac dysfunction and development of heart failure.
por: Ertl, G, et al.
Publicado em: (1993)

Effects of LTD4 and its specific antagonist L-660,711 in isolated rat hearts with chronic myocardial infarction
por: Han, H, et al.
Publicado em: (1994)

Effects of LTD4 and its specific antagonist L-660,711 in isolated rat hearts with chronic myocardial infarction.
por: Han, H, et al.
Publicado em: (1994)

Indication of ACE-inhibitors post-myocardial infarction
por: Ertl, G, et al.
Publicado em: (1994)

Myocardial contractile efficiency increases in proportion to a fetal enzyme shift in chronically infarcted rat hearts.
por: Naumann, A, et al.
Publicado em: (2005)

Alterations of performance and oxygen utilization in chronically infarcted rat hearts.
por: Tian, R, et al.
Publicado em: (1996)

Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction.
por: Neubauer, S, et al.
Publicado em: (1995)

Changes of creatine kinase gene expression in rat heart post-myocardial infarction.
por: Neubauer, S, et al.
Publicado em: (1998)

Preservation of left ventricular mechanical function and energy metabolism in rats after myocardial infarction by the angiotensin-converting enzyme inhibitor quinapril.
por: Horn, M, et al.
Publicado em: (1996)

Prevention with angiotensin-converting enzyme (ACE) inhibitors
por: Ertl, G, et al.
Publicado em: (1992)

[Prevention with angiotensin-converting enzyme (ACE) inhibitors]
por: Ertl, G, et al.
Publicado em: (1992)

Quality of Life of Patients with Heart Failure Due to Myocardial Ischemia
por: Grażyna Bonek-Wytrych, et al.
Publicado em: (2024-09-01)

[Indications for ACE inhibitors in the postinfarct period]
por: Ertl, G, et al.
Publicado em: (1994)

Effects of endothelin-1 in the isolated heart in ischemia/reperfusion and hypoxia/reoxygenation injury.
por: Neubauer, S, et al.
Publicado em: (1991)

Effect of mediators on coronary circulation.
por: Ertl, G, et al.
Publicado em: (1991)

Beta-blockers in cardiac failure.
por: Neubauer, G, et al.
Publicado em: (1994)

High-dose 17beta-estradiol treatment prevents development of heart failure post-myocardial infarction in the rat.
por: Beer, S, et al.
Publicado em: (2007)

Chronic high-dose creatine feeding does not attenuate left ventricular remodeling in rat hearts post-myocardial infarction.
por: Horn, M, et al.
Publicado em: (1999)

Mechanisms of the effects of nicorandil in the isolated rat heart during ischemia and reperfusion: a 31P-nuclear magnetic resonance study.
por: Horn, M, et al.
Publicado em: (2001)

Magnetic resonance imaging of the heart
por: Neubauer, S, et al.
Publicado em: (1993)

Endothelin-1 contributes to ischemia/reperfusion injury in isolated rat heart-attenuation of ischemic injury by the endothelin-1 antagonists BQ123 and BQ610.
por: Han, H, et al.
Publicado em: (1995)

[Stepwise diagnosis of heart failure]
por: Neubauer, S, et al.
Publicado em: (1993)

Staged diagnosis in heart failure
por: Neubauer, S, et al.
Publicado em: (1993)

Computed tomography and magnetic resonance tomography in cases of coronary heart disease
por: Lackner, K, et al.
Publicado em: (1990)

[Computed tomography and magnetic resonance tomography in cases of coronary heart disease]
por: Lackner, K, et al.
Publicado em: (1990)

Cardiac 31P-MR-spectroscopy in myocardial insufficiency
por: Krahe, T, et al.
Publicado em: (1993)

[31P-cardio-MR-spectroscopy in myocardial insufficiency]
por: Krahe, T, et al.
Publicado em: (1993)

[Magnetic resonance spectroscopy of the heart. Its clinical importance]
por: Neubauer, S, et al.
Publicado em: (1993)

Functional and energetic consequences of chronic myocardial creatine depletion by beta-guanidinopropionate in perfused hearts and in intact rats.
por: Neubauer, S, et al.
Publicado em: (1999)

The Role of Myocardial Ischemia in the Course of Heart Failure with Preserved Ejection Fraction in Patients with Cardiorenal Metabolic Syndrome
por: Yevhen Yu. Marushko, et al.
Publicado em: (2024-09-01)

Increased uncoupling protein 2 expression in heart failure, but not compensated hypertrophy, post-myocardial infarction
por: Murray, A, et al.
Publicado em: (2002)

Targeting mir128-3p alleviates myocardial insulin resistance and prevents ischemia-induced heart failure
por: Andrea Ruiz-Velasco, et al.
Publicado em: (2020-03-01)

QT interval dispersion, myocardial ischemia duration, and coronary atherosclerosis severity interaction in coronary heart disease patients with painless myocardial ischemia episodes
por: Yu. N. Fedulaev, et al.
Publicado em: (2006-10-01)